Butorphanol Tartrate Spray
Product Images NDC 60505-0813

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Butorphanol Tartrate (NDC 60505-0813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

An instructional illustration showing a person holding a tissue to their nose, demonstrating nasal usage technique, relevant for nasal spray administration.*

FDA Label Image

Figure2.jpg (Figure2)

An instructional illustration showing assembly or parts of a nasal spray device, including the spray bottle, nozzle, and a removable cap, with arrows indicating directions for attaching or removing components.*

FDA Label Image

Figure3.jpg (Figure3)

An illustration of a hand holding a nasal spray device, showing the proper grip and positioning for administration of the spray.*

FDA Label Image

Figure4.jpg (Figure4)

Illustration showing a person drinking a glass of liquid using a straw. The diagram focuses on the face and hand, demonstrating the action of sipping from the straw.*

FDA Label Image

Figure5.jpg (Figure5)

An instructional illustration showing a person using a nasal spray. The person appears to be holding the nasal spray with one hand and preparing to use it in one nostril, depicting proper usage technique.*

FDA Label Image

Figure6.jpg (Figure6)

Illustration showing a person administering Butorphanol Tartrate nasal spray by inserting the spray nozzle into one nostril and spraying the medication.*

FDA Label Image

Figure7.jpg (Figure7)

FDA Label Image

Btl-lbl-2.5ml.jpg (Btl Lbl 2.5ml)

Label for Butorphanol Tartrate Nasal Solution USP 10 mg/mL spray in a 2.5 mL volume. The label indicates nasal use only, storage instructions at 20° to 25°C, and is labeled by Apotex Corp., Toronto, Ontario, Canada. Contains the NDC 60505-0813.*

FDA Label Image

Figure.jpg (Figure)

A pharmacokinetic graph showing plasma concentration (ng/mL) of Butorphanol Tartrate over time (hours) following three administration routes: intravenous (IV), nasal spray (NS), and intramuscular (IM). Plasma concentration is plotted on a logarithmic scale, illustrating concentration decline over 12 hours with data points and error bars for each route.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of Butorphanol Tartrate, showing the molecular configuration of the active ingredient in the product Butorphanol Tartrate nasal spray 10 mg/mL by Apotex Corp.*

FDA Label Image

Symbol.jpg (Symbol)

Butorphanol Tartrate nasal spray 10 mg/mL packaging label displaying the product name, strength, and nasal spray dosage form. The label includes Apotex Corp. as the manufacturer. The design features a combination of text and color elements on the container.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.